Home/Filings/4/0001801170-25-000207
4//SEC Filing

Garipalli Vivek 4

Accession 0001801170-25-000207

CIK 0001801170other

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 4:07 PM ET

Size

11.9 KB

Accession

0001801170-25-000207

Insider Transaction Report

Form 4
Period: 2025-08-07
Garipalli Vivek
Director10% Owner
Transactions
  • Purchase

    Class A Common Stock

    2025-08-07$2.24/sh+415,000$929,6001,824,267 total
  • Purchase

    Class A Common Stock

    2025-08-08$2.17/sh+31,980$69,3971,856,247 total
Holdings
  • Class B Common Stock

    Class A Common Stock (6,904,343 underlying)
    6,904,343
  • Class B Common Stock

    (indirect: By LLC)
    Class A Common Stock (11,500,000 underlying)
    11,500,000
  • Class B Common Stock

    (indirect: By LLC)
    Class A Common Stock (72,084,543 underlying)
    72,084,543
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.16 to $2.32, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this Footnote 1 to this Form 4.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $2.15 to $2.21, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this Footnote 2 to this Form 4.
  • [F3]The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.
  • [F4]The Reporting Person serves as the sole manager of each of NJ Healthcare Investments, LLC and Caesar Clover, LLC.

Issuer

CLOVER HEALTH INVESTMENTS, CORP. /DE

CIK 0001801170

Entity typeother

Related Parties

1
  • filerCIK 0001839260

Filing Metadata

Form type
4
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 4:07 PM ET
Size
11.9 KB